Ebitda Изменить Дата
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Celltrion KRW 19.64B 1.85B 2026-03
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -46.46M 6.27M 2026-03
Divis Laboratories Ltd INR 12.62B 3.28B 2026-06
Gilead Sciences USD 3.51B 489M 2026-03
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
MacroGenics USD -30.2M 52.15M 2026-03
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Organigram Holdings CAD -4.76M 10.02M 2026-03
Pfizer USD 6.01B 18M 2026-06
Pharma Mar EUR 700K 2.01M 2026-06
Qiagen NV USD 207.66M 59.56M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Sartorius EUR 280.5M 13.2M 2026-06
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Takeda JPY 364.46B 214.21B 2026-06
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -379M 348.47M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03